Brief #67855Updated 18 NOV 2025GERMANTOWNMEDICAL ORGANIZATIONSSERIES B
Employbl DossierDeka Biosciences
Deka Biosciences, Inc., is an early-stage biotechnology company focused on generating the next generation targeted cytokine therapies to treat cancer and inflammatory diseases.
- Founded
- 2018
- Headcount
- 44
- Open roles
- 0
- Last raised
- Series B · $20M
Section II · Premium ProfileMembers only
- 01Engineering interview process at Deka BiosciencesLocked
- 02Tech stack & infrastructure choicesLocked
- 03Culture & day-to-day work styleLocked
- 04Why join now vs. 6 months from nowLocked
- 05Hiring focus & open headcount by teamLocked
- 06Comp philosophy and band contextLocked
7-day free trial · $25/mo · cancel anytime
